Immunosenescence is a concept used to describe the age-associated deterioration of immune function, characterized by functional and phenotypic changes on both cellular and systemic levels [1, 2] . Immunosenescence in elderly people is associated with an increased susceptibility to infectious diseases, impaired response to vaccinations, and increased incidence of cancer and autoimmunity [3] [4] [5] . During immune aging, senescent T cells accumulate in the peripheral T cell pool [2, 6, 7] . By repetitive antigenic stimulation of T cells, their telomeres are shortened [8] and the expression of CD28, a co-stimulatory molecule, is lost [9] . In humans, cytomegalovirus (CMV) is known to be one of the most important antigens that cause repetitive T cell stimulation [10, 11] . As a result of such repetitive stimulation, CD28
null T cells accumulate during the immune aging process [12] . Similarly, the expression of CD57 antigen on T cells is currently considered to be another surrogate marker of the replicative senescence of T cells [13] . CD57 is a terminally sulfated glycan carbohydrate epitope, and CD57 + T cells showed an inability to proliferate after antigenic stimulation in vitro and a high susceptibility to activation-induced apoptosis [14, 15] (Figure 1) . Compared to CD28 + CD57 -T cells, CD57 + T cells produce more proinflammatory cytokines and exert greater cytotoxicity [16] . These senescent CD57 + T cells are known to be associated with a number of inflammatory diseases in humans [17] [18] [19] .
Recent studies have reported the association between senescent T cells and various cardiovascular diseases. Accelerated telomere shortening in T cells and peripheral blood mononuclear cells (PBMCs) was seen in patients with atherosclerosis [20] and myocardial infarction [21] . Higher frequencies of CD8
+ T cells were associated with an increased prevalence of carotid artery lesions in a study of human immunodeficiency virus-infected patients [22] . Liuzzo et al. [23] reported that the number of CD4 null T cells could be the main source of IFN-γ production in patients with UA. Furthermore, it was shown that a higher frequency of CD4 + CD28 null T cells was associated with the recurrence of acute coronary events in UA patients [24] . Patients who experienced recurrent acute coronary events had a higher frequency of CD4 + CD28
null T cells than those with a single episode during 4 years of follow-up. Another study found that the number of CD4 + CD28
null T cells is expanded in patients with diabetes mellitus, and this expansion is associated with poor glycemic control [25] . The presence of these senescent T cells also correlates with the occurrence of a first cardiovascular event and with worse outcomes after an acute coronary syndrome. Senescent T cells have been studied not only in conjunction with atherosclerotic disease but also with hypertension [26] . Patients with hypertension had an increased frequency of circulating CD8 + cytotoxic T cells bearing surface markers of replicative senescence, which is characterized by the loss of CD28 and the acquisition of CD57. These individuals also had higher circulating levels of the C-X-C chemokine (CXC) receptor type 3 chemokines, such as CXCL9, CXCL10, and CXCL11. The frequency of CD8 + T cells producing perforin, granzyme B, IFN-γ, or tumor necrosis factor (TNF)-α was increased in the peripheral blood of hypertensive patients than in that of healthy controls. However, there was no difference in the frequency of regulatory T cells and IL-17-producing CD8 + T cells between the two groups. Immunohistochemical staining of kidney sections from patients with hypertensive nephrosclerosis revealed an in- Arterial stiffening is one of the major mechanisms for the pathogenesis of hypertension [27] , and arterial stiffness is increased in the presence of established cardiovascular risk factors including aging [28] . The degree of arterial stiffness is known to be associated with various markers of inflammation [29, 30] , suggesting a certain role for immunological factors in increasing arterial stiffness. In this regard, we recently studied whether T cell immunosenescence is associated with arterial stiffness evaluated by pulse wave velocity (PWV) in Koreans. We found that the frequency of CD57 + cells in the CD8 + T cell population was independently correlated with the PWV, even after adjusting for age, sex, systolic blood pressure, diabetes mellitus history, smoking history, body mass index, creatinine, high-density lipoprotein cholesterol, and high sensitivity C-reactive protein (data not published). We also studied CMV-specific T cell responses since CMV is a major driving antigen for the replicative senescence of T cells [10, 11] . The frequency of CMV-specific IFN-γ or TNF-α secretion or the cytotoxic function of CD8 + T cells was positively correlated with PWV in multivariate analysis (data not published). Recently, the significance of CMV infection in increased arterial stiffness was also reported by Wall et al. [31] . They demonstrated that arterial stiffness was higher in the CMVseropositive group than in the CMV-seronegative group among patients with chronic kidney disease.
In summary, T cell senescence can be evaluated by the frequency of CD28 null T cells or CD57 + T cells in PBMCs. CMV is a major factor accelerating T cell senescence. T cell senescence is related to cardiovascular diseases such as atherosclerosis, acute myocardial infarction, and hypertension. It is also associated with increased arterial stiffness. The roles of T cell senescence and CMV infection in cardiovascular disease need to be validated in large cohort studies, and the mechanism by which senescent T cells contribute to the pathogenesis of cardiovascular disease requires further investigation. 
